Research & Development
Academic Report
Combination of Plasma Aβ42/40 and p-tau217 Measured Using Fully Automated Immunoassay System Accurately Predicts Amyloid Pathology Determined by Amyloid PET
| Presented by: | Masanori Kurihara1)2), Kazuto Yamashita3), Shun Murakami3), Kengo Ishiki3), Tomomi Masuda4), Yoshikazu Okamura4), Masahiro Miura3), Kenji Ishii2)5), Toshiyuki Sato3), Atsushi Iwata1)2) |
| 1) Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology 2) Department of Biomarkers, Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology 3) Central Research Laboratories, Sysmex Corporation 4) Medical & Scientific Affairs, Sysmex Corporation 5) Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology |
|
| Academic conference: |
18th Clinical Trials on Alzheimer's Disease (CTAD) |
| Presentation Date: | December 3, 2025 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.